Vascular Endothelial Growth Factor Inhibitor
- Name
- Vascular Endothelial Growth Factor Inhibitor
- Accession Number
- DBCAT003817
- Description
Not Available
- Drugs
Drug Drug Description Bevacizumab A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer. Ranibizumab A recombinant humanized monoclonal antibody and VEGF-A antagonist used for the management of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. Aflibercept A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer Brolucizumab An anti VEGF-A monoclonal antibody indicated to treat neovascular age related macular degeneration. - Drugs & Drug Targets